Literature DB >> 35143389

Surveillance for stage I testicular cancer: Maximizing benefit and minimizing harm.

Piotr Czaykowski1.   

Abstract

Entities:  

Year:  2022        PMID： 35143389      PMCID： PMC8932422          DOI： 10.5489/cuaj.7754

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  4 in total

1.  Canadian consensus guidelines for the management of testicular germ cell cancer.

Authors:  Lori Wood; Christian Kollmannsberger; Michael Jewett; Peter Chung; Sebastian Hotte; Martin O'Malley; Joan Sweet; Lynn Anson-Cartwright; Eric Winquist; Scott North; Scott Tyldesley; Jeremy Sturgeon; Mary Gospodarowicz; Roanne Segal; Tina Cheng; Peter Venner; Malcolm Moore; Peter Albers; Robert Huddart; Craig Nichols; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

2.  Temporal trends in management and outcomes of testicular cancer: A population-based study.

Authors:  Michael J Leveridge; D Robert Siemens; Kelly Brennan; Jason P Izard; Safiya Karim; Howard An; William J Mackillop; Christopher M Booth
Journal:  Cancer       Date:  2018-04-16       Impact factor: 6.860

3.  Cancer Death Risk Related to Radiation Exposure from Computed Tomography Scanning Among Testicular Cancer Patients.

Authors:  Eeva Salminen; Hannele Niiniviita; Hannu Järvinen; Sirpa Heinävaara
Journal:  Anticancer Res       Date:  2017-02       Impact factor: 2.480

4.  Use of imaging for active surveillance in testicular cancer: Is real-world practice concordant with guidelines?

Authors:  Bishal Gyawali; Rebecca Griffiths; Andrew G Robinson; Matthew D F McInnes; Philippe L Bedard; Christopher M Booth
Journal:  Can Urol Assoc J       Date:  2022-02       Impact factor: 2.052
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.